CA 15-3 is breast tumor marker. Diagnostic tests measuring the MUC1- glycoprotein are FDA/EU approved including CA 15-3, CA 27-29 and Br assays. Reoccurrence detection of breast cancer by MUC-1 assay can preceed confirmation by radiological detection methods by 1-9 months.
Pathway
IL-7 Signaling Pathway; Metabolism of proteins; O-linked glycosylation; O-linked glycosylation of mucins; Post-translational protein modification; Termination of O-glycan biosynthesis;
Citations
Publication ()
Have you cited DCABY-4605 in a publication? Let us know and earn a reward for your research.
My Review for Magic™ Anti-MUC1 monoclonal antibody, clone N302322
Creative Diagnostics products are for RESEARCH USE ONLY, please make sure your review is research based.
Required fields are marked with *
Terms and conditions:
We will select high-quality review customers and offer a $30 coupon for your next purchase.
All product reviews must be submitted in the English language.
Creative Diagnostics will not share any personal information of applicants, and all information will be treated with strict confidentiality and will not be sold or disclosed to a third party.
COA
Publication 
Loading ......
